Screening happens once. Operations happen every day. Here's which problem each one actually solves.
Gabify started as an AI developmental screening company. Neurolens, their flagship product, uses voice and video analysis to flag early indicators in children. It's a genuine piece of clinical technology and it's what they've raised money to build.
TheraFlow started as an operating and revenue backbone for therapy centres. Scheduling, prepaid packages, dues, attendance, retention, and multi-location reporting — the work that happens every day after a child has been assessed and enrolled.
A screening result doesn't collect your dues, fill your empty slots, or tell you which family stopped showing up three weeks ago.
So the question isn't which product is better. It's which problem is costing you more right now — getting children through the door, or running the centre once they're in it.
Based on Gabify's public product and pricing pages as of July 2026. A dash means we couldn't find it documented — not that it doesn't exist. If we've got something wrong, tell us and we'll correct it.
| What centres need | Gabify | TheraFlow |
|---|---|---|
| AI developmental screening | Neurolens — their core product | We don't build screening |
| Clinically validated screening dataset | Claims AIIMS Jodhpur / ICMR validation | Not our domain |
| Referral marketplace for families | Stated as available | Not offered |
| Session scheduling across multiple therapists | Available | Built for it |
| Prepaid packages & silent-expiry alerts | Not published | Auto expiry alerts |
| Revenue recovery & dues dashboard | Not published | ₹35K–₹60K recovered in 90 days |
| Retention alerts by attendance pattern | Not published | Before the family drops off |
| Multi-location utilisation & revenue reporting | Operates across locations; reporting depth not published | Per-therapist, per-location, real time |
| 60-second therapist handover | Not published | Full context from any phone |
| Parent app with progress photos | Available | Core feature |
| WhatsApp reminders, receipts & summaries | Available | Fully automated |
| GST invoicing | Available | Available |
| Free setup & data migration | Not published | Included, ~2 hours |
| Pricing model | ₹1,299/user/month (introductory) | ₹7,999/month flat, unlimited therapists |
AI developmental screening
Gabify
Neurolens — their core product
TheraFlow
We don't build screening
Clinically validated screening dataset
Gabify
Claims AIIMS Jodhpur / ICMR validation
TheraFlow
Not our domain
Referral marketplace for families
Gabify
Stated as available
TheraFlow
Not offered
Session scheduling across multiple therapists
Gabify
Available
TheraFlow
Built for it
Prepaid packages & silent-expiry alerts
Gabify
Not published
TheraFlow
Auto expiry alerts
Revenue recovery & dues dashboard
Gabify
Not published
TheraFlow
₹35K–₹60K recovered in 90 days
Retention alerts by attendance pattern
Gabify
Not published
TheraFlow
Before the family drops off
Multi-location utilisation & revenue reporting
Gabify
Operates across locations; reporting depth not published
TheraFlow
Per-therapist, per-location, real time
60-second therapist handover
Gabify
Not published
TheraFlow
Full context from any phone
Parent app with progress photos
Gabify
Available
TheraFlow
Core feature
WhatsApp reminders, receipts & summaries
Gabify
Available
TheraFlow
Fully automated
GST invoicing
Gabify
Available
TheraFlow
Available
Free setup & data migration
Gabify
Not published
TheraFlow
Included, ~2 hours
Pricing model
Gabify
₹1,299/user/month (introductory)
TheraFlow
₹7,999/month flat, unlimited therapists
Gabify's introductory rate is ₹1,299 per user, per month. TheraFlow is ₹7,999 a month, flat — unlimited therapists, unlimited patients, no per-patient fees.
That difference doesn't matter for a solo therapist. It matters a lot for a centre. Here's the same maths applied to real therapist counts, at their introductory rate:
| Therapists | Gabify | TheraFlow |
|---|---|---|
| 3 | ₹3,897 | ₹7,999 |
| 6 | ₹7,794 | ₹9,999 |
| 8 | ₹10,392 | ₹9,999 |
| 12 | ₹15,588 | ₹9,999 |
| 20 | ₹25,980 | ₹14,999 |
The lines cross at roughly eight therapists — and that's before the introductory period ends. Two questions worth asking any vendor offering a launch price: what is the standard rate, and what happens to yours at renewal?
The better question than "what does it cost" is "what does it return".
Our average centre recovers ₹35,000 to ₹60,000 in the first 90 days — packages that were quietly expiring, dues nobody chased, slots that sat empty. That's the number to hold any practice management software against, ours included.
Yes. We don't build developmental screening, and we're not claiming to. Screening is a clinical assessment that happens once, before therapy starts. TheraFlow is the system that runs the centre delivering the therapy afterwards — every day, for years. They're different jobs, and we'd rather do ours properly than add a checkbox.
For one to five therapists, yes. TheraFlow is flat — ₹7,999/month covers unlimited therapists and patients. Gabify's introductory rate is charged per user, so the two cross over at roughly eight therapists and the gap widens from there. Multiply their rate by your actual therapist count before comparing, and check what the price becomes when the introductory period ends.
That's a reasonable setup, and we'd tell you so. Use a screening tool for intake assessment and TheraFlow for operations. We'd rather you run the right tool for each job than pick one that does both at half depth.
Screening, genuinely. Neurolens is their core product, they've raised funding specifically to build it, and they cite AIIMS Jodhpur and ICMR validation. If early developmental flagging is your bottleneck, look at them seriously — ask to see the published validation, as you should with any clinical claim.
Yes. 7-day free trial, free data migration, and setup in about two hours. Run it against one real week of your centre's operations — attendance, dues, package expiry — and you'll know.
Run TheraFlow against one real week of your centre — attendance, dues, package expiry, no-shows. You'll know by Friday.